annual CFI:
-$205.60M-$180.41M(-716.36%)Summary
- As of today (June 17, 2025), MLTX annual cash flow from investing activities is -$205.60 million, with the most recent change of -$180.41 million (-716.36%) on December 31, 2024.
- MLTX annual CFI is now -716.36% below its all-time high of -$25.18 million, reached on December 31, 2023.
Performance
MLTX Cash from investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CFI:
$56.25M+$203.58M(+138.18%)Summary
- As of today (June 17, 2025), MLTX quarterly cash flow from investing activities is $56.25 million, with the most recent change of +$203.58 million (+138.18%) on March 31, 2025.
- Over the past year, MLTX quarterly CFI has increased by +$85.05 million (+295.27%).
- MLTX quarterly CFI is now -51.87% below its all-time high of $116.87 million, reached on December 31, 2023.
Performance
MLTX quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFI:
-$120.55M+$85.05M(+41.37%)Summary
- As of today (June 17, 2025), MLTX TTM cash flow from investing activities is -$120.55 million, with the most recent change of +$85.05 million (+41.37%) on March 31, 2025.
- Over the past year, MLTX TTM CFI has dropped by -$46.91 million (-63.70%).
- MLTX TTM CFI is now -305.70% below its all-time high of $58.60 million, reached on September 30, 2024.
Performance
MLTX TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash from investing Formula
CFI = Cash Inflows from Investments − Cash Outflows for Investments
MLTX Cash from investing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -716.4% | +295.3% | -63.7% |
| 3 y3 years | - | +10000.0% | -10000.0% |
| 5 y5 years | - | - | - |
MLTX Cash from investing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -716.4% | at low | -51.9% | +132.3% | -305.7% | +41.4% |
| 5 y | 5-year | -716.4% | at low | -51.9% | +132.3% | -305.7% | +41.4% |
| alltime | all time | -716.4% | at low | -51.9% | +132.3% | -305.7% | +41.4% |
MLTX Cash from investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | $56.25M(-138.2%) | -$120.55M(-41.4%) |
| Dec 2024 | -$205.60M(+716.4%) | -$147.33M(-352.8%) | -$205.60M(-450.8%) |
| Sep 2024 | - | $58.28M(-166.4%) | $58.60M(-133.7%) |
| Jun 2024 | - | -$87.74M(+204.6%) | -$174.06M(+136.4%) |
| Mar 2024 | - | -$28.80M(-124.6%) | -$73.64M(+192.4%) |
| Dec 2023 | -$25.18M | $116.87M(-167.0%) | -$25.18M(-80.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2023 | - | -$174.38M(-1475.6%) | -$132.15M(<-9900.0%) |
| Jun 2023 | - | $12.68M(-35.5%) | $0.00(-100.0%) |
| Mar 2023 | - | $19.65M(+98.4%) | -$12.68M(-60.8%) |
| Dec 2022 | -$32.34M | $9.90M(-123.4%) | -$32.34M(-23.4%) |
| Sep 2022 | - | -$42.23M(<-9900.0%) | -$42.24M(>+9900.0%) |
| Jun 2022 | - | $0.00(-100.0%) | -$16.00K(0.0%) |
| Mar 2022 | - | -$16.00K | -$16.00K |
FAQ
- What is MoonLake Immunotherapeutics annual cash flow from investing activities?
- What is the all time high annual CFI for MoonLake Immunotherapeutics?
- What is MoonLake Immunotherapeutics annual CFI year-on-year change?
- What is MoonLake Immunotherapeutics quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for MoonLake Immunotherapeutics?
- What is MoonLake Immunotherapeutics quarterly CFI year-on-year change?
- What is MoonLake Immunotherapeutics TTM cash flow from investing activities?
- What is the all time high TTM CFI for MoonLake Immunotherapeutics?
- What is MoonLake Immunotherapeutics TTM CFI year-on-year change?
What is MoonLake Immunotherapeutics annual cash flow from investing activities?
The current annual CFI of MLTX is -$205.60M
What is the all time high annual CFI for MoonLake Immunotherapeutics?
MoonLake Immunotherapeutics all-time high annual cash flow from investing activities is -$25.18M
What is MoonLake Immunotherapeutics annual CFI year-on-year change?
Over the past year, MLTX annual cash flow from investing activities has changed by -$180.41M (-716.36%)
What is MoonLake Immunotherapeutics quarterly cash flow from investing activities?
The current quarterly CFI of MLTX is $56.25M
What is the all time high quarterly CFI for MoonLake Immunotherapeutics?
MoonLake Immunotherapeutics all-time high quarterly cash flow from investing activities is $116.87M
What is MoonLake Immunotherapeutics quarterly CFI year-on-year change?
Over the past year, MLTX quarterly cash flow from investing activities has changed by +$85.05M (+295.27%)
What is MoonLake Immunotherapeutics TTM cash flow from investing activities?
The current TTM CFI of MLTX is -$120.55M
What is the all time high TTM CFI for MoonLake Immunotherapeutics?
MoonLake Immunotherapeutics all-time high TTM cash flow from investing activities is $58.60M
What is MoonLake Immunotherapeutics TTM CFI year-on-year change?
Over the past year, MLTX TTM cash flow from investing activities has changed by -$46.91M (-63.70%)